Susan M. Frayne, MD, MPH

home / authors / susan-m-frayne-md-mph

Articles

November 30th 2015

Anticoagulation in Atrial Fibrillation: Impact of Mental Illness

Susan K. Schmitt, PhD Mintu P. Turakhia, MD, MAS Ciaran S. Phibbs, PhD Rudolf H. Moos, PhD Dan Berlowitz, MD, MPH Paul Heidenreich, MD, MS Victor Y. Chiu, MD Alan S. Go, MD Sarah A. Friedman, MSPH Claire T. Than, MPH Susan M. Frayne, MD, MPH

Atrial fibrillation patients with mental health conditions are less likely to be eligible for warfarin receipt, and those who are eligible receive warfarin at lower rates.

September 6th 2011

Mental Illness and Warfarin Use in Atrial Fibrillation

Graham A. Walker, MD Paul A. Heidenreich, MD, MS Ciaran S. Phibbs, PhD Alan S. Go, MD Victor Y. Chiu, BA Susan K. Schmitt, PhD Lakshmi Ananth, MS Susan M. Frayne, MD, MPH

Atrial fibrillation patients with mental illness are less likely to receive warfarin anticoagulation; those who do receive warfarin have excess risk of over-anticoagulation.

April 2nd 2009

Does Opioid Therapy Affect Quality of Care for Diabetes Mellitus?

Adam J. Rose, MD, MSc John A. Hermos, MD Susan M. Frayne, MD, MPH Leonard M. Pogach, MD, MBA Dan R. Berlowitz, MD, MPH Donald R. Miller, ScD

Within the Veterans Affairs system, diabetes performance measures were similar in patients who received chronic opioid therapy and in those who did not.